Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT06434779
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT06434779
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06434779. Allocation not applicable; no masking; primary purpose treatment. Start 2024-07 (anticipated); primary completion 2026-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART)
- Acronym
- JETART
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- JETi 6F and 8F Thrombectomy system
- Lead sponsor
- Vascular Science LP GmbH
- Collaborator
- ID3 Medical
- Collaborator
- Abbott
Record details
- Record id
cardio:ct-nct06434779- Content hash
f126cc4c5f5d63785fdd9a179f66acd58fcd6a0d310f86b4d9fc890f15346600